- Home
- Products
- Customized FluoroAb™
- CD40LG
- Toralizumab-Cy5
Toralizumab-Cy5 (CAT#: ADC-FL-807)
This product is comprised of an anti-CD40LG monoclonal antibody (Toralizumab) labeled with cy5. cy5 is a far-red-fluorescent dye and it's excitation/emission is 649/666 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD40LG
- Alternative Names
- CD40LG; CD40 ligand; HIGM1, IMD3, TNFSF5, tumor necrosis factor (ligand) superfamily, member 5 (hyper IgM syndrome); CD40 antigen ligand; CD40L; CD154; gp39; hCD40L; hyper IgM syndrome; T B cell activating molecule; TNF related activation protein; TRAP; internalized inside cells, the cytosol provides reducing environment including intracellular enzyme protein disulfide isomerase, or similar enzymes, drugs can be released.
- Overview
- The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome.
- Overview
- Humanized Anti-CD40L IgG1-kappa antibody, Toralizumab
- Generic name
- Toralizumab
- Species Reactivity
- Human
- Name
- Cy5
- Color
- Far-red
- Excitation⁄Emission (nm)
- 649/666
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-NCA-90 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13906)
- Anti-CD22 MAb (Clone 20)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15918)
- Anti-CD33 MAb (Clone 19)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5642)
- Anti-MUC16 MAb (Clone 6)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS468)
- Anti-MET MAb (Clone 20)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13717)
- Anti-TFPI MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15342)
- Samalizumab-Coumarin (CAT#: ADC-FL-427)
- Anti-LYPD3 MAb (Clone 4)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13221)
- Anti-HBV MAb (Clone 4)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13890)
- Anti-SLC44A4 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12781)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-807. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-920 | Anti-CD40LG (Toralizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2444 | Anti-CD40LG (Dapirolizumab pegol)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-922 | Anti-CD40LG (Toralizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-917 | Anti-CD40LG (Ruplizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-2447 | Anti-CD40LG (Dapirolizumab pegol)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
